Fri, March 11, 2022
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022
Sun, March 6, 2022
Fri, March 4, 2022
Thu, March 3, 2022

Yanan Zhu Maintained (BLUE) at Hold with Decreased Target to $8 on, Mar 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-8-on-mar-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yanan Zhu of Wells Fargo, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $12 to $8 on, Mar 8th, 2022.

Yanan has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Yanan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $10 on, Monday, March 7th, 2022


These are the ratings of the 3 analyists that currently disagree with Yanan


  • Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $4 on, Monday, March 7th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022
  • Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $10 on, Monday, November 8th, 2021

Publication Contributing Sources